Prominent players in the market include Bachem AG, PolyPeptide Group, CPC Scientific Inc., Lonza Group Ltd., CordenPharma ...

Legend Biotech has managed to remove GenScript Biotech as its majority shareholder, just as the former parent’s Chinese background falls under a U.S. biosecurity microscope. After a financial maneuver ...

Genscript Biotech (HK:1548) has released an update. Genscript Biotech has announced the deconsolidation of its subsidiary, Legend Biotech, following changes to their deposit agreement. This strategic ...

(Reuters) -The U.S. House of Representatives committee on China on Tuesday sent a letter to the directors of the FBI and national intelligence, renewing its concerns about GenScript Biotechnology's ...

Genscript Biotech Corporation has announced the resignation of Dr. Liu Zhenyu from his role as rotating chief executive officer, effective 31 December 2024, as he pursues personal career development.